期刊文献+

阳离子PLGA载基因纳米粒的初步研究 被引量:4

Preliminary studies on pDNA loaded cationic PLGA nanoparticles
下载PDF
导出
摘要 目的制备并评价阳离子PLGA载基因纳米粒(pDNA-CTAB-NPs)。方法纳米沉淀法制备空白阳离子PLGA纳米粒(CTAB-NPs),与报告基因pEGFP复合,考察其理化性质、抗核酸酶降解能力、体外释药特性、细胞毒性及其在A549细胞中的转染情况。结果pDNA-CTAB-NPs呈球形或类球形,平均粒径175.5 nm,Zeta电位+12.54mV,pDNA结合充分(>95%),抗核酸酶降解能力强,具有缓释效果,符合Higuchi释放动力学方程(r=0.997 7),细胞毒性较低,能在A549细胞中表达。结论pDNA-CTAB-NPs是一种制备工艺简单,性能良好,极富潜力的非病毒纳米基因载体。 Purpose To prepare and to investigate the pDNA loaded cationic PLGA nanopartieles(pDNA- CTAB-NPs). Methods Blank cationic PLGA nanoparticles (CTAB-NPs)were prepared by nanoprecipitation method, and the report gene pEGFP was incubated with the CTAB-NPs at room temperature leading to the formation of the pDNA-CTAB-NPs. The physico-chemical properties, protection of the pDNA-CTAB-NPs to pDNA from nuclease degradation, release behaviour, in vitro cytotoxicity as well as transfection activity of pDNA-CTAB-NPs were evaluated respectively. Results The obtained pDNA-CTAB-NPs were approximately spherical in shape with average particle size of 175.5 nm, Zeta potentials of + 12.54 inV. The CTAB-NPs could combine pDNA thoroughly( 〉 95 % ) and protect pDNA from nuclease degradation. It showed low eyto- toxicity to A549 cells and manifested sustained-release of pDNA in vitro within 25 days with the release behavior in accordance with Higuchi equation ( r = 0. 997 7 ). The gene transfection experiment in vitro suggested that pDNA-CTAB-NPs could transfer the loaded gene into A549 cells, and the gene could express well inside the cells. Conclusion pDNA-CTAB-NPs could be prepared easily with excellent characteristics that could be a promising non-viral nano-device. It has the potential to make in vivo cancer gene therapy achievable.
出处 《中国生化药物杂志》 CAS CSCD 北大核心 2009年第2期78-81,共4页 Chinese Journal of Biochemical Pharmaceutics
基金 国家自然科学基金资助项目(30572267)
关键词 阳离子PLGA纳米粒 CTAB 非病毒基因载体 cationic PLGA nanoparticles CTAB non-viral gene vector
  • 相关文献

参考文献10

  • 1杨菁,宋存先,李拥军,管珩,李大勇.纳米粒子作为基因载体在不同动物模型上的基因转染效果[J].中国医学科学院学报,2006,28(4):475-480. 被引量:2
  • 2Tabatt K, Kneuer C, Sameti M, et al. Transfection with different colloidal systems: compareson of solid lipid nanoparticles and liposomes [J].J Controlled Release, 2004,97 (2) : 321-332.
  • 3Dunne M, Bibby D C, Jones J C , et al. Encapsulation of protamine sulphate compacted DNA in polylactide and polylactide-co-glycolide microparticles [ J ]. J Controlled Release, 2003,92 ( 1-2 ) : 209- 219.
  • 4何勤,张志荣,刘戟,周益芬,卢懿,聂飞.荧光法测定载基因纳米粒的包封率[J].华西药学杂志,2002,17(1):49-50. 被引量:6
  • 5Barman S P, Lunsford L, Chambers P, et al. Two methods for quantifying DNA extracted from poly ( lactideco-glycolide ) microspheres [ J ]. J Controlled Release, 2000,69 : 337-344.
  • 6Bilati U, Allemann E, Doelker E. Development of a nanopreeipitation method intended for the entrapment of hydrophilic drugs into nanopartictes[J]. Eur J Pharm Sei, 2005,24( 1 ) : 67-75.
  • 7Agarwal A, Vilensky R, Stockdale A, et al. Colloidally stable novel copolymeric system for gene delivery in complete growth media[J]. J Controlled Release, 2007,121 (1-2) : 28-37.
  • 8Perez C, Sanchez A, Putnam D, et al. Poly( lactic acid)-poly( ethylene glycol) nanoparticles as new carriers for the delivery of plasmid pDNA [J]. J Controlled Release, 2001,75 : 211-224.
  • 9Basarkar A, Devineni D, Palaniappan R, Singh J. Preparation, charac- terizatlon, cytotoxicity and transfection efficiency of poly(DL-lactide-co- glycolide) and poly(DL-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA [J]. Int J Pharm, 2007,343 (1-2) : 247- 54.
  • 10黄伟,崔光华,贺俊峰,周旭,张强.壳聚糖纳米粒用作基因递送载体的初步研究[J].药学学报,2002,37(12):981-985. 被引量:28

二级参考文献20

  • 1F.奥斯伯 颜子颖(译).精编分子生物学实验指南[M].北京:科学出版社,1998.141.
  • 2Walter E, Dreher D, Kok M, et al. Hydrophilic poly(D,L-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic celles [J]. J Controlled Release, 2001,76(1-2):149-168.
  • 3Truong-Le VL, August JT, Leong KW. Controlled gene delivery by DNA-gelatin nanospheres [J]. Hum Gene Ther, 1998,9(12):1709-1717.
  • 4Li XW, Liu JL, Wei YQ, et al. Preparation of polysaccharide nanoparticles for controlled gene release [J]. J Pharm Pharmacol, 1999,51(Supplement):176.
  • 5Hirosue S, Muller BG, Mulligan RC, et al. Pasmid DNA encapsulation and released from solvent diffusion nanospheres [J]. J Controlled Release, 2001,70(1-2):231-242.
  • 6Barman SP, Lunsford L, Chambers P, et al. Two methods for quantifying DNA extracted from poly(lactide-co-glycolide) microspheres [J]. J Controlled Release, 2000,69(3):337-344.
  • 7Crystal RG. The gene as the drug [J]. Nat Med, 1995,1(1):15-17.
  • 8Tomlinson E, Rolland AP. Controllable gene therapy: Pharmaceutics of non-viral gene delivery systems [J]. J Controlled Release, 1996,39(2-3):357-372.
  • 9Mulligan RC. The basic sciences of gene therapy [J]. Science, 1993,260(5110):926-932.
  • 10Du BH. Gene Therapy: Principle and Practice [M]. Tianjin: Tianjin Science and Technology Press, 1999.90-91.

共引文献32

同被引文献48

  • 1林全愧,计剑,谭庆刚,任科峰,沈家骢.层层自组装技术在生物医用材料领域中的应用研究进展[J].高分子通报,2006(8):58-63. 被引量:27
  • 2秦志强,罗赛群,胡维新.非病毒基因转运系统的研究进展[J].国际病理科学与临床杂志,2007,27(2):141-144. 被引量:2
  • 3El-Aneed A.An overview of current delivery systems in cancer gene therapy[J].J Controlled Release,2004,94(1):1-14.
  • 4Wattendorf U,Merkle H P.PEGylation as a tool for the biomedical engineering of surface modified microparticles[J].J Pharm Sci,2008,97(11):4655-4669.
  • 5Gunnarsson A,J(O)nsson P,Marie R,et al.Single-molecule detection and mismatch discrimination of unlabeled DNA targets[J].Nano Lett,2008,8(1):183-188.
  • 6Zhang L,Gu F X,Chan J M,et al.Nanoparticles in medicine:therapeutic applications and developments[J].Clin Pharmacol Ther,2008,83(5):761-769.
  • 7Gao Y,Gu W,Chen L,et al.A multifunetional nano device as nonviral vector for gene delivery:In titro characteristics and transfection[J].J Controlled Release,2007,118(3):381-388.
  • 8Kwok K Y,Park Y,Yang Y,et al.In vivo gene transfer using sulfhydryl cross-linked PEG-peptide/glycopeptide DNA co-condensates[J].J Pharm Sci,2003,92:1174-1185.
  • 9Kwok K Y,McKenzie D L,Evers D L,et al.Formulation of highly soluble poly(ethylene glycol)-peptide DNA condensates[J].J Pharm Sci,1999,88:996-1003.
  • 10Morille M,Passirani C,Vonarbourg A,et al.Progress in developing cationic vectors for non-viral systemic gene therapy against cancer[J].Biomaterials,2008,29(24-25):3477-3496.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部